ID,Neutralizing Antibody Titer (MNA Assay (ND50)) at Time Point -2,Binding Antibody Titer (ELISA Assay (IgG ELU/mL)) at Time Point -2,Neutralizing Antibody Titer (MNA Assay (ND50)) at Time Point 14,Binding Antibody Titer (ELISA Assay (IgG ELU/mL)) at Time Point 14,Neutralizing Antibody Titer (MNA Assay (ND50)) at Time Point 28,Binding Antibody Titer (ELISA Assay (IgG ELU/mL)) at Time Point 28,Infection Group
1,<LLOQ (58),< LLOQ (50.3),540,69.5,936,1387.7,Sustained
2,<LLOQ (58),< LLOQ (50.3),1773,6560,1771,2166.3,Sustained
3,<LLOQ (58),< LLOQ (50.3),506,455.7,862,2500,Sustained
4,<LLOQ (58),< LLOQ (50.3),1143,968.6,825,2631.7,Sustained
5,<LLOQ (58),< LLOQ (50.3),261,86.1,471,532.4,Sustained
6,<LLOQ (58),< LLOQ (50.3),402,55.4,1003,292.1,Sustained
7,<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),472,536.6,Transient
8,<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),Transient
9,<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),Transient
10,<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),Abortive
11,126,202.1,143,211.5,171,203,Abortive
12,<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),Abortive
13,<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),Abortive
14,<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),Abortive
15,<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),Abortive
16,<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),<LLOQ (58),< LLOQ (50.3),Abortive